Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.120
+0.010 (0.47%)
At close: Aug 11, 2026, 4:00 PM EDT
2.140
+0.020 (0.94%)
Pre-market: Aug 12, 2026, 9:19 AM EDT
Grace Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
44.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 151.12M |
| Aligos Therapeutics | 31.52M |
| Veru Inc. | 16.89M |
| Metagenomi Therapeutics | 13.56M |
| Seres Therapeutics | 1.88M |
| CervoMed | 331.30K |
| Serina Therapeutics | 130.00K |
| Impact BioMedical | 35.00K |
GRCE News
- 7 days ago - Grace Therapeutics to issue 4.762M shares at $2.10 in private placement - TheFly
- 7 days ago - Grace Therapeutics initiates dual-source manufacturing strategy for GTx-104 - TheFly
- 7 days ago - Grace Therapeutics Announces $10 Million Private Placement - GlobeNewsWire
- 15 days ago - Grace Therapeutics Proxy statement: Proxy filing - Filings
- 15 days ago - Grace Therapeutics Proxy statement: Proxy filing - Filings
- 15 days ago - Grace Therapeutics receives Type A meeting minutes from FDA - TheFly
- 15 days ago - Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration - GlobeNewsWire
- 16 days ago - Grace Therapeutics Slides: Corporate presentation - Filings